357613-77-5

357613-77-5 structure

Name: galiximab
Chemical Name: galiximab
CAS Number: 357613-77-5
Molecular Formula:
Molecular Weight:
Catalog: Research Areas Cancer
Create Date: 2018-06-21 16:48:17
Modify Date: 2025-09-19 15:55:07
Galiximab (IDEC 114) is a primatized immunoglobulin G1 (IgG1) lambda monoclonal antibody directed against the CD80 antigen. Galiximab has variable regions are primatized (cynomologous monkeys), and the constant regions are human. Galiximab can be used in research of B-cell lymphoma[1].

Name	galiximab

Description	Galiximab (IDEC 114) is a primatized immunoglobulin G1 (IgG1) lambda monoclonal antibody directed against the CD80 antigen. Galiximab has variable regions are primatized (cynomologous monkeys), and the constant regions are human. Galiximab can be used in research of B-cell lymphoma[1].
Related Catalog	Research Areas >> Cancer
Target	CD80[1]
References	[1]. Smith SM, et, al. The anti-CD80 primatized monoclonal antibody, galiximab, is well-tolerated but has limited activity in relapsed Hodgkin lymphoma: Cancer and Leukemia Group B 50602 (Alliance). Leuk Lymphoma. 2013 Jul;54(7):1405-10.

No Any Chemical & Physical Properties